Antibodies, Monoclonal, HumanizedAntineoplastic Combined Chemotherapy ProtocolsLung Neoplasms
Dr. Samer S. Kasbari, MD, MS
NPI1881702595PAC ID0749245710
- Medicare services, 2024
- 151,345
- Medicare patients, 2024
- 1,117
- Part D claims, 2024
- 3,038
- Publications
- 5
- Clinical trials
- 10
- Practice address
- 203 Cox Blvd, Goldsboro, NC 27534
- Practice phone
- Call (919) 580-0000
- Professional email
- Get professional email
- Personal email
- Get personal email
- Mobile number
- Get mobile number
Primary practice
Southeastern Medical Oncology Center
Goldsboro, North Carolina
Find Dr. Kasbari's professional email, personal email and mobile number
Dmand AI checks each channel through healthcare-specific waterfall enrichment. See what is on file with a free account, with practice phones, licenses and affiliations.
Dr. Samer S. Kasbari is a hematologist and oncologist in Goldsboro, North Carolina
Dr. Kasbari practices at Southeastern Medical Oncology Center in Goldsboro, North Carolina.
Dr. Kasbari's NPI, 1881702595, was assigned on August 25, 2006. Dr. Kasbari holds North Carolina license 2008-00829.
NPI and contact details
- NPI
- 1881702595NPI Registry (opens in a new tab)
- Medicare PAC ID
- 0749245710
- NPI enumeration date
- August 25, 2006
- NPI status
- Active
- Accepts Medicare assignment
- Yes
- Practice phone
- (919) 580-0000
- Professional email
- Get email
- Personal email
- Get email
- Mobile number
- Get number
- Sex
- Male
- Estimated age
- 51
- Medical school graduation
- 2001
Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; Dmand AI Practice Data; and Doctors and Clinicians National Downloadable File (CMS)
Dr. Samer S. Kasbari practices at Southeastern Medical Oncology Center in Goldsboro, North Carolina
Dr. Kasbari's primary practice is Southeastern Medical Oncology Center, at 203 Cox Blvd, Goldsboro, NC 27534 in Wayne County. The practice phone is (919) 580-0000.
- Southeastern Medical Oncology Center203 Cox Blvd, Goldsboro, NC 27534 · Wayne CountyPhone(919) 580-0000
Sources: NPPES NPI Registry (CMS); and Dmand AI Practice Data
Dr. Samer S. Kasbari is affiliated with 9 sites of care and 2 medical groups
Dr. Kasbari's primary practice is Southeastern Medical Oncology Center in Goldsboro, North Carolina. Dr. Kasbari is also affiliated with UNC Health Wayne. The medical group on file is UNC Health Wayne. Dmand AI also links Dr. Kasbari to 4 more hospitals, 1 group practice or clinic, 1 home health agency, 1 hospice and 1 medical group, each named with a free account.
Southeastern Medical Oncology CenterPrimary
Sources: NPPES NPI Registry (CMS); Dmand AI Practice Data; and Dmand AI Affiliation Data
Dmand AI tracks the EHR system at Dr. Samer S. Kasbari's practice
Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Kasbari practices, 8 sites in all. Vendor and product names are available with a free account.
| Site | EHR vendor and product |
|---|---|
| Southeastern Medical Oncology Center | Available with a free account |
| +8 more sites and 1 medical group | Available with a free account |
Source: Dmand AI Technology Install Data
For health IT teams
See the EHR and IT leaders at every site where Dr. Kasbari practices
Dmand AI maps EHR vendors, IT decision makers and buying committees across each health system and 6.2K+ hospitals, with verified contacts in the same login.
Dr. Samer S. Kasbari is one of 420 hematologists and oncologists in North Carolina
Hematology and oncology is Dr. Kasbari's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dmand AI has Dr. Kasbari's licenses on file in 2 states: North Carolina and New Hampshire.
Specialties and state licenses
- Hematology and oncology, North CarolinaPrimary
- New Hampshire license
Hematologists and oncologists near Dr. Kasbari
Counts of hematologists and oncologists with a Dmand AI profile, by place and practice. Each opens the list.
420hematologists and oncologists in North Carolina
3hematologists and oncologists in Goldsboro
Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; and Dmand AI Peer Benchmarks
Dr. Samer S. Kasbari billed Medicare for 151,345 services in 2024
CMS data shows 151,345 Medicare services from Dr. Kasbari across 53 procedure codes in 2024, for 1,117 Medicare patients. Medicare paid $813,480 for them.
Medicare services, 2024151,345
Medicare patients1,117
Paid by Medicare$813,480
Procedure codes53
Dr. Kasbari's Medicare services by type, 2023 to 2024
- 2023
- 2024
- Drugs given in the office
- 2023: 78,2072024: 108,68439%
- Other services
- 2023: 13,3232024: 31,237134%
- Lab and pathology
- 2023: 4,2832024: 4,72110%
- Tests and treatments
- 2023: 3,3742024: 3,369No change
- Office and hospital visits
- 2023: 1,9842024: 1,9263%
- Surgery
- 2023: 1,4032024: 1,408No change
Where Dr. Kasbari's Medicare services took place, 2024
- In an office151,217100%
- In a facility1280%
Dr. Kasbari compared with the North Carolina median for hematologists and oncologists, 2024
- Dr. Kasbari
- North Carolina median
- Medicare services
- 151,345vs 450336.3 times
- Medicare patients
- 1,117vs 1806.2 times
- Part D claims
- 2,665vs 3248.2 times
Medians across 402 hematologists and oncologists in North Carolina with Dmand AI profiles that report each measure.
Dr. Kasbari's most billed Medicare procedure codes, 2024
CMS publishes codes billed for 11 or more Medicare patients. Each label is the code family; CPT descriptions are licensed by the AMA.
Need commercial claims for Dr. Kasbari?
Medicare shows one payer. Book a meeting to get commercial claims data for Dr. Kasbari and other hematologists and oncologists in North Carolina.
Sources: Medicare Physician & Other Practitioners - by Provider and Service (CMS), 2024 data; and Dmand AI Peer Benchmarks
Dr. Samer S. Kasbari treated 1,117 Medicare patients in 2024, average age 75
CMS counts 1,117 Medicare patients who saw Dr. Kasbari in 2024. The largest group is 65 to 74, with 437 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 13% are also on Medicaid. Their average risk score is 1.78, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.
Across all payers, Dmand AI patient panel data puts Dr. Kasbari's median patient age at 69, with 70% women.
Medicare patients, 20241,117
Average age75
Average risk score1.78
Also on Medicaid13%
Dr. Kasbari's Medicare patients by age, 2024
Dr. Kasbari's Medicare patients by sex, 2024
- Women70163%
- Men41637%
Chronic conditions among Dr. Kasbari's Medicare patients, 2024
- High blood pressure75%
- High cholesterol75%
- Arthritis44%
- Cancer41%
- Diabetes40%
- Chronic kidney disease38%
- Ischemic heart disease33%
- Osteoporosis30%
Share of Medicare patients with each condition. A patient can have several.
Dr. Kasbari's patients across all payers
Dmand AI patient panel data covers Medicare, Medicaid and commercial patients.
Patient panel by age, all payers
Median age 69
Patient panel by sex, all payers
- Women70%
- Men30%
Sources: Dmand AI Patient Panel Data; and Medicare Physician & Other Practitioners - by Provider (CMS), 2024 data
Dr. Samer S. Kasbari wrote 3,038 Medicare Part D claims in 2024
In 2024, Dr. Kasbari wrote 3,038 Medicare Part D claims for 484 patients. 73% of them were for generic drugs. CMS names the drug for 2,665 of them, across 67 drugs with 11 or more claims each, at $6,132,391 in total drug cost. In 2023, CMS named 2,241 claims across 56 drugs.
Part D claims, 20243,038
Drugs named by CMS67
Total drug cost$6.1M
Part D patients484
Dr. Kasbari's Part D claims by kind of drug, 2024
- Generic2,229 claims73%
- Brand-name809 claims27%
Dr. Kasbari's most prescribed drugs by claims, 2024
CMS names a drug when it has 11 or more claims. Share is of the claims for drugs CMS names.
Drug classes CMS tracks in Dr. Kasbari's Part D claims, 2024
- Opioids11%322 of 3,038 claims
- Antibiotics3%79 of 3,038 claims
Share of all Part D claims for each drug class CMS reports on. Classes with no claims are left out.
Part D claims for drugs CMS names, 2023 to 2024
- 2023
- 2024
- Claims for drugs CMS names
- 2023: 2,2412024: 2,66519%
Drugs named by CMS: 67 in 2024, 56 in 2023.
Sources: Medicare Part D Prescribers - by Provider and Drug (CMS), 2024 data, released May 6, 2026; and Medicare Part D Prescribers - by Provider (CMS), 2024 data
Dr. Samer S. Kasbari scored 99 out of 100 in Medicare's MIPS program for 2024
CMS publishes a Merit-based Incentive Payment System (MIPS) score of 99 out of 100 for Dr. Kasbari for performance year 2024, reported as part of a group. Dr. Kasbari accepts Medicare assignment, so Medicare's approved amount is taken as full payment.
- Accepts Medicare assignment
- Yes
Dr. Kasbari's MIPS scores, performance year 2024
- 99of 100Final score
- 94.4of 100Quality
- 40of 100Improvement Activities
Each score is out of 100. The final score weighs the categories CMS scored for this clinician.
Sources: Doctors and Clinicians National Downloadable File (CMS); and Clinician Public Reporting: Overall MIPS Performance (CMS), 2024 data, released September 10, 2026
For MedTech and pharma teams
Find hematologists and oncologists like Dr. Kasbari by procedure volume and prescribing
Filter 7.4M+ HCPs by Medicare procedures, Part D drugs and Open Payments history, then reach them with verified contacts in one login.
Dr. Samer S. Kasbari has 5 publications on record
Dmand AI links 5 papers to Dr. Kasbari, published from 2017 to 2024. Dr. Kasbari's most frequent co-authors are Edem S. Agamah, MD, Krishna C. Alluri, MD and Sunil Babu, MD.
Papers5
Years published2017 to 2024
Dr. Kasbari's papers by year, 2017 to 2024
Dr. Kasbari's most frequent co-authors
Recent publications by Dr. Kasbari
Breast Cancer Res Treat
Antineoplastic AgentsBreast NeoplasmsPeripheral Nervous System Diseases
See who Dr. Kasbari researches with
Physician Network Discovery turns co-authorship, shared hospitals and shared groups into a map of who Dr. Kasbari works with, so you can find a warm path to the right hematologists and oncologists.
Sources: PubMed (National Library of Medicine); and Dmand AI Research Linkage
Dr. Samer S. Kasbari has worked on 10 clinical trials
Dmand AI links Dr. Kasbari to 10 clinical trials, 8 of them phase 3 studies. 9 are still active or recruiting. Conditions studied include Carcinoma, Non-Small-Cell Lung, Adenocarcinoma of Lung and Anal Canal Carcinoma. National Cancer Institute (NCI) sponsors the most, 8.
Clinical trials with Dr. Kasbari by phase
- NonePhase 1: no trials
- 1Phase 2: 1 trial
- 1Phase 2/3: 1 trial
- 8Phase 3: 8 trials
- NonePhase 4: no trials
Conditions in Dr. Kasbari's trials
- Carcinoma, Non-Small-Cell Lung
- Adenocarcinoma of Lung
- Anal Canal Carcinoma
- Breast Carcinoma In Situ
- Carcinosarcoma
Investigators on the most trials with Dr. Kasbari
- Misbah Ul-Ahsan Qadir, MD8 shared trials
- Bret Edward Buckley Friday, MD6 shared trials
- Nafisa D. Burhani, MD5 shared trials
Recent clinical trials with Dr. Kasbari
Randomized Phase II/III Study of Venetoclax (ABT199) Plus Chemoimmunotherapy for MYC/BCL2 Double-Hit and Double Expressing Lymphomas (opens in a new tab)
Active, not recruitingPhase 2/3
Lymphoma, Large B-Cell, DiffuseLymphoma, B-CellVenetoclaxCyclophosphamideDoxorubicin Hydrochloride
Rectal DiseasesColorectal NeoplasmsAtezolizumabBevacizumabFluorouracil
A Randomized Phase III Study of Immune Checkpoint Inhibition With Chemotherapy in Treatment-Naive Metastatic Anal Cancer Patients (opens in a new tab)
Active, not recruitingPhase 3
Anal Canal CarcinomaAnus NeoplasmsCarboplatinNivolumabPaclitaxel
Testing the Effects of MK-3475 (Pembrolizumab) With or Without the Usual Chemotherapy Treatment for Patients 70 Years of Age and Older With Advanced Non-small Cell Lung Cancer (opens in a new tab)
Active, not recruitingPhase 2
Adenocarcinoma of LungCarcinoma, Non-Small-Cell LungPembrolizumabCarboplatinPemetrexed
Testing the Addition of the Immunotherapy Drug Pembrolizumab to the Usual Chemotherapy Treatment (Paclitaxel and Carboplatin) in Stage III-IV or Recurrent Endometrial Cancer (opens in a new tab)
Active, not recruitingPhase 3
CarcinosarcomaNeoplasms, Complex and MixedCarboplatinPaclitaxelPembrolizumab
Sources: Dmand AI Research Linkage; and ClinicalTrials.gov (National Library of Medicine)
Dr. Samer S. Kasbari received $312,215 in industry payments from 2016 to 2025
CMS Open Payments shows 586 general payments to Dr. Kasbari from 65 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 76% of the total. Bristol-Myers Squibb Company paid the most, $229,868.
General payments to Dr. Kasbari by program year, 2016 to 2025
General payments to Dr. Kasbari by kind, 2016 to 2025
$312.2Kin total
- Speaker and faculty fees$237,82376%
- Travel and lodging$48,81516%
- Consulting fees$11,4104%
- Food and beverage$8,8033%
- Other$4,1491%
Companies that paid Dr. Kasbari the most, 2016 to 2025
Share is of all general payments to this clinician.
Source: Open Payments (CMS), 2025 data, released July 7, 2026
Sources for Dr. Samer S. Kasbari's profile data
Data last refreshed October 2026Report an inaccuracyRemove my information
FAQ
Frequently asked questions about Dr. Samer S. Kasbari
Spotted something out of date? Email hello@dmand.ai and we will check the record. Contact details live in the free trial.
What is Dr. Samer S. Kasbari's NPI number?
Dr. Samer S. Kasbari's NPI number is 1881702595. It was assigned on August 25, 2006, and it is active in the NPI Registry.
What kind of doctor is Dr. Samer S. Kasbari?
Dr. Samer S. Kasbari is a hematologist and oncologist in Goldsboro, North Carolina. The primary specialty in the NPI Registry is Hematology & Oncology Physician (taxonomy code 207RH0003X).
Where does Dr. Samer S. Kasbari practice?
Dr. Kasbari practices at 203 Cox Blvd, Goldsboro, NC 27534. Dr. Kasbari's primary practice is Southeastern Medical Oncology Center in Goldsboro, North Carolina. Dmand AI also links Dr. Kasbari to 4 hospitals, 1 group practice or clinic, 1 home health agency, 1 hospice and 1 medical group.
What is Dr. Samer S. Kasbari's office phone number?
The practice phone on file for Dr. Kasbari is (919) 580-0000.
What is Dr. Samer S. Kasbari's medical license number?
Dr. Kasbari holds North Carolina license 2008-00829, one of the licenses on file in 2 states.
Which states has Dr. Samer S. Kasbari been licensed in?
Dmand AI has state licenses on file for Dr. Kasbari in North Carolina and New Hampshire.
Which hospitals is Dr. Samer S. Kasbari affiliated with?
Dr. Kasbari is affiliated with UNC Health Wayne. Dmand AI links Dr. Kasbari to 4 more hospitals.
What medical group is Dr. Samer S. Kasbari part of?
Dr. Kasbari is linked to UNC Health Wayne. Dmand AI links Dr. Kasbari to 1 more medical group.
Does Dr. Samer S. Kasbari accept Medicare?
Yes. CMS data shows Dr. Kasbari billed Medicare for 151,345 services in 2024, and Dr. Kasbari accepts Medicare assignment.
What is Dr. Samer S. Kasbari's MIPS score?
Dr. Kasbari's MIPS final score for performance year 2024 is 99 out of 100, reported as part of a group.
Show 7 more questionsShow fewer questions
How many Medicare patients does Dr. Samer S. Kasbari see?
CMS counts 1,117 Medicare patients who saw Dr. Kasbari in 2024, with an average age of 75.
What services does Dr. Samer S. Kasbari bill to Medicare?
In 2024, Dr. Kasbari's most billed Medicare services were injected or infused drug (J1439), medicare temporary code (Q0138) and injected or infused drug (J0881).
What drugs does Dr. Samer S. Kasbari prescribe most?
In 2024 Medicare Part D data, Dr. Kasbari's most prescribed drugs by claims were Anastrozole, Tamoxifen Citrate and Ondansetron HCl.
Has Dr. Samer S. Kasbari received payments from drug or device companies?
CMS Open Payments shows $312,215 in general payments to Dr. Kasbari from 65 companies from 2016 to 2025. The largest total came from Bristol-Myers Squibb Company.
How long has Dr. Samer S. Kasbari been practicing?
Dr. Kasbari graduated from medical school in 2001, 25 years ago.
Does Dr. Samer S. Kasbari do research?
Dmand AI links 5 publications to Dr. Kasbari, published from 2017 to 2024. Dr. Kasbari has worked on 10 clinical trials.
Who does Dr. Samer S. Kasbari publish with?
Dr. Kasbari's most frequent co-authors are Edem S. Agamah, MD (1 shared paper), Krishna C. Alluri, MD (1 shared paper) and Sunil Babu, MD (1 shared paper).
Selling to hematology and oncology practices?
See hematologists and oncologists in North Carolina by site of care and group
Find the practices, groups and hospitals they work with, and the right people to contact at each.
- 30 days free
- Self-serve
- No credit card